Viking's Obesity Drug Data Fuels Bets It Can Rival Lilly's Zepbound
Viking Therapeutics reports that patients maintained weight loss on its VK2735 drug, boosting investor confidence in its potential to compete with Eli Lilly.
Headline and summary written by an AI model from the linked articles; not reviewed by a person. How this was made
This story has stopped developing; this page is its permanent record. More from that day
The odds
Each tick is a source publishing on this story
Price data
| Time | Chance of yes |
|---|---|
| now | 13% |
| 24 Sept, 15:45 UTC | 13% |
| 23 Sept, 08:53 UTC | 14% |
| 22 Sept, 19:10 UTC | 17% |
| 22 Sept, 17:54 UTC | 16% |
| 21 Sept, 17:36 UTC | 14% |
The story so far
2 publishers have covered this in 2 articles since 22 Sept 2026. MarketWatch published first, on 22 September at 15:46 UTC; Quartz followed 1h 28m later. The most recent article, from Quartz, appeared on 22 September at 17:14 UTC.
Outlets reporting it: MarketWatch, Quartz.
One prediction market prices this story:
- Will Viking Therapeutics be acquired before 2027? — the market puts it at 13%, with $78 traded in the last 24 hours, closing 1 Jan 2027. The market resolves to Yes if credible reporting confirms an acquisition agreement by December 31, 2026, at 11:59 PM ET. The outcome depends on a signed deal rather than the final completion of the transaction. Readers often mistake the deadline as the end of 2027 instead of the specified date in late 2026.
Odds are the market's probability that the outcome happens, updated every few minutes. They are information about what traders expect, not a forecast we make and not investment advice.
Sources
Every article we clustered into this story. Headlines link to the publisher.
Related prediction markets
Linked by software because they are about the same subject. Most ask a different question from the one this story reports, so read each market's own question. How often the link is right
- Polymarket Will Viking Therapeutics be acquired before 2027? 13% −1
Does the market have this right?
Wrong market?
Have your say
Your call. How does this end?
Free, no money involved. Calls are scored against the market's price when you make them, so backing an underdog that wins scores most. Leaderboard · Your calls
Email me when the odds move
In this story
- Viking Therapeutics
- Eli Lilly